PH12020550059A1 - Novel ophthalmic composition and methods of use - Google Patents

Novel ophthalmic composition and methods of use

Info

Publication number
PH12020550059A1
PH12020550059A1 PH12020550059A PH12020550059A PH12020550059A1 PH 12020550059 A1 PH12020550059 A1 PH 12020550059A1 PH 12020550059 A PH12020550059 A PH 12020550059A PH 12020550059 A PH12020550059 A PH 12020550059A PH 12020550059 A1 PH12020550059 A1 PH 12020550059A1
Authority
PH
Philippines
Prior art keywords
infection
methods
ophthalmic composition
novel ophthalmic
eye
Prior art date
Application number
PH12020550059A
Other languages
English (en)
Inventor
Joseph Capriotti
Kara Capriotte
Jesse Pelletier
Kevin Stewart
Original Assignee
Veloce Biopharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veloce Biopharma Llc filed Critical Veloce Biopharma Llc
Publication of PH12020550059A1 publication Critical patent/PH12020550059A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH12020550059A 2017-08-22 2020-02-21 Novel ophthalmic composition and methods of use PH12020550059A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2017/048063 WO2019040051A1 (fr) 2017-08-22 2017-08-22 Nouvelle composition ophtalmique et méthodes d'utilisation

Publications (1)

Publication Number Publication Date
PH12020550059A1 true PH12020550059A1 (en) 2020-10-19

Family

ID=65439513

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12020550059A PH12020550059A1 (en) 2017-08-22 2020-02-21 Novel ophthalmic composition and methods of use

Country Status (3)

Country Link
EP (1) EP3672572A4 (fr)
PH (1) PH12020550059A1 (fr)
WO (1) WO2019040051A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126127A (en) * 1991-07-16 1992-06-30 Euroceltique, S.A. Stabilized PVP-I solutions
US20170071979A1 (en) * 2011-05-11 2017-03-16 Veloce Biopharma, Llc Composition and method for treating otitis
KR20190032629A (ko) * 2015-01-20 2019-03-27 벨로체 바이오파르마 엘엘씨 신규한 요오드포 조성물 및 사용 방법
US9770466B2 (en) * 2015-07-02 2017-09-26 Veloce Biopharma, Llc Ophthalmic composition and methods of use

Also Published As

Publication number Publication date
WO2019040051A1 (fr) 2019-02-28
EP3672572A1 (fr) 2020-07-01
EP3672572A4 (fr) 2021-01-06

Similar Documents

Publication Publication Date Title
AU2018256591A1 (en) Thieno[3,2-d]pyrimidines derivatives for the treatment of viral infections
EP4374851A3 (fr) Composition ophtalmique pour le traitement d'une maladie de l' il sec
PH12017501300A1 (en) Novel iodophor composition and methods of use
MX2024007658A (es) Composiciones y metodos de uso de nintedanib para mejorar el exito de la cirugia del glaucoma.
SA523440384B1 (ar) مركبات الفوسفوليبيدات واستخداماتها
NZ728072A (en) Modulators of toll-like receptors for the treatment of hiv
EP4681776A3 (fr) Thérapie antimicrobienne
EP4292650A3 (fr) Composés hétérocycliques en tant qu'immunomodulateurs
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
EP4599848A3 (fr) Procédés et compositions associés à un traitement combiné avec anti-inflammatoires et nanovecteurs synthétiques comprenant un immunosuppresseur
MY169159A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
EP4026835A3 (fr) Inhibiteurs de pd-1/pd-l1
WO2017083431A3 (fr) Composés à base d'hydroxypyridinone et d'hydroxypyrimidinone pour le traitement d'infections bactériennes
EP4417262A3 (fr) Polythérapie
GEP20247585B (en) Furoindazole derivatives
PH12019500083A1 (en) Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections
EP4289820A3 (fr) Composes pour traiter la maladie d'alzheimer dans des patients apoe4+/+
MX2020006191A (es) Bacteriocinas terapeuticas.
WO2019200314A3 (fr) Analogues d'hinokitiol, procédés de préparation et compositions pharmaceutiques de ceux-ci
AU2017248276A1 (en) Methods of treating ocular conditions
EP4272832A3 (fr) Composés antimicrobiens, compositions et leurs utilisations
PH12021550122A1 (en) Solubilized apyrases, methods and use
MX2020000402A (es) Nuevos derivados de xantina sustituidos.
MX2026002367A (es) Composiciones de copolimero de bloque sensibles al ph, micelas, y metodos de uso
EP4420722A3 (fr) Facteurs de croissance des fibroblastes modifiés pour le traitement de troubles oculaires